treatment-resistant depression
data-content-type="article"
FDA allows treatment of depression with club drug's cousin
This photo provided by Janssen Global Services shows Spravato nasal spray. Spravato, a mind-altering medication related to the club drug Special K, won U.S. approval Tuesday, March 5, for patients with hard-to-treat depression, the first in a series of long-overlooked substances being reconsidered for severe forms of mental illness. (Janssen Global Services via AP)
overrideBackgroundColorOrImage=
overrideTextColor=
overrideTextAlignment=
overrideCardHideSection=
overrideCardHideByline=
overrideCardHideDescription=
overridebuttonBgColor=
overrideButtonText=
overrideTextAlignment=